STERIS plc presents a strong positioning within the healthcare and medical device industry. With a diversified portfolio focusing on infection prevention technologies, the company shows resilience. Investors may consider STE as a potential buy given its consistent performance metrics and favorable industry trends.
The fundamental analysis of STERIS plc suggests a solid performance in key financial metrics.
| Category | Score | Visual |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 2 | |
| Price to Earnings | 2 | |
| Price to Book | 2 |
The historical scores show consistency in fundamental metrics, reinforcing its value proposition.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-02-24 | 3 | 3 | 4 | 4 | 2 | 2 | 2 |
| Previous | 0 | 3 | 4 | 4 | 2 | 2 | 2 |
Analysts predict a strong growth trajectory with favorable price targets.
| High | Low | Median | Consensus |
|---|---|---|---|
| $265 | $245 | $260 | $256.67 |
Analyst sentiment for STERIS plc is predominantly positive, signaling confidence in future performance.
| Recommendation | Count | Visual |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 11 | |
| Hold | 2 | |
| Sell | 0 | |
| Strong Sell | 0 |
STERIS plc exhibits solid financial stability and growth potential, bolstered by its involvement in the resilient healthcare sector. While the company's debts warrant careful monitoring, the overall positive analyst sentiment and favorable price targets suggest a bright future. Investors may find STERIS plc appealing given its stability and the projected industry growth. The consistent fundamental scores further underline the company's reliability and value.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.